Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China
· Delayed Price · Currency is CNY 44.85
+0.41 (0.92%)
May 30, 2025, 2:45 PM CST
Hangzhou Biotest Biotech Market Cap
Hangzhou Biotest Biotech has a market cap or net worth of 4.66 billion as of May 30, 2025. Its market cap has increased by 55.67% in one year.
Market Cap
4.66B
Enterprise Value
3.04B
Revenue
511.66M
Ranking
n/a
PE Ratio
34.27
Stock Price
44.85
Market Cap Chart
Since September 8, 2021, Hangzhou Biotest Biotech's market cap has decreased from 8.23B to 4.66B, a decrease of -43.34%. That is a compound annual growth rate of -14.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 4.66B | 35.03% |
| Dec 31, 2024 | 3.45B | 6.92% |
| Dec 29, 2023 | 3.23B | -34.48% |
| Dec 30, 2022 | 4.93B | -33.91% |
| Dec 31, 2021 | 7.46B | -9.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 358.49B |
| Shenzhen Mindray Bio-Medical Electronics | 275.39B |
| WuXi AppTec | 185.29B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.16B |
| Sichuan Biokin Pharmaceutical | 120.77B |
| Aier Eye Hospital Group | 115.43B |
| Shanghai United Imaging Healthcare | 113.37B |
| Yunnan Baiyao Group Co.,Ltd | 100.78B |